Open Access

Add on to take back control: Combining lipid lowering therapies for the management of high and very high risk patients

Event: ESC Congress 2021 - The Digital Experience
Topic: Lipids
Session type: Satellite Symposium
Sponsored by Daiichi Sankyo Europe
Date: 28 August 2021
Time: 19:00 - 19:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

7 presentations in this session

Welcome and introduction.

Speaker: Professor K. Ray (London, GB)
Thumbnail

Reflections on SANTORINI.

Speaker: Professor K. Ray (London, GB)
Thumbnail

Patient background considerations and unmet need.

Speaker: Professor E. Stroes (Amsterdam, NL)
Thumbnail

The need for add-on oral therapy: patient cases.

Speaker: Professor U. Laufs (Leipzig, DE)
Thumbnail

Expectations for managing patient outcomes.

Speaker: Professor U. Laufs (Leipzig, DE)
Thumbnail

Understanding the landscape and need to implement guidelines.

Speaker: Professor K. Ray (London, GB)
Thumbnail

Meeting close.

Speaker: Professor E. Stroes (Amsterdam, NL)
Thumbnail

7 speakers from this session

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
3 followers

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
3 followers

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
24 presentations
0 follower

Professor Ulrich Laufs

University hospital Leipzig AoR, Leipzig (Germany)
30 presentations
1 follower

Professor Ulrich Laufs

University hospital Leipzig AoR, Leipzig (Germany)
30 presentations
1 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
3 followers

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
24 presentations
0 follower

Related content

ESC Premium Access

Regional Clinical Trials

4 December 2021

ESC Premium Access

ESC Guidelines 2021 - Valvular Heart Disease

3 December 2021

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

This platform is supported by

logo Novo Nordisk